A major University of Oxford observational study confirms that myocarditis and pericarditis occurred exclusively among children and adolescents who received Covid-19 vaccines, with no documented cases in unvaccinated peers during the research period. Published as a preprint in May 2024 on medRxiv through the OpenSAFELY platform, the analysis reviewed health records of approximately 1.7 million children and adolescents in England. Researchers found roughly 27 cases of myocarditis or pericarditis per million children following their first vaccine dose and about 10 cases per million after the second dose—though actual cardiac events numbered in the dozens across the vaccinated group.
The study’s senior author, William Hulme, clarified that the 1.7 million figure represents the total population screened, not those affected by cardiac inflammation. While pharmaceutical advocates note the preprint has not undergone full peer review and did not compare infection-triggered myocarditis with vaccine-related cases in identical timeframes, the findings align with global surveillance data showing a consistent temporal association between mRNA vaccines—particularly the second dose—and cardiac inflammation in adolescent males since 2021.
These results arrive as public health authorities reevaluate pediatric vaccination policies. The CDC recently concluded that it no longer recommends Covid-19 shots for healthy children and pregnant women due to the identified risk signal. The OpenSAFELY dataset provides one of the largest real-world comparisons yet between vaccinated and unvaccinated youth, raising questions about why healthy children were administered experimental mRNA vaccines under emergency authorization when cardiac events exclusively appeared in the vaccinated cohort.
The study underscores the critical need for transparent risk-benefit analysis rather than blanket recommendations for low-risk populations, emphasizing that informed consent requires clear articulation of therapeutic contraindications—a principle central to biomedical ethics.
